Literature DB >> 20740339

Does the handling time of unrefrigerated human fecal specimens impact the detection of Clostridium difficile toxins in a hospital setting?

Chintan Modi1, Joseph R DePasquale, Nhat Q Nguyen, Judith E Malinowski, George Perez.   

Abstract

BACKGROUND: The stability of Clostridium difficile toxins is an important factor in determining the accuracy of the enzyme immunoassay (EIA). The Centers for Disease Control has stated that C. difficile toxins may become undetectable in unrefrigerated stool specimens within 2 h after collection.
PURPOSE: The purpose of our study was to determine how the unrefrigerated handling time of human fecal specimens affects the results of C. difficile infection (CDI) testing.
METHODS: A retrospective review of CDI testing with Premier™ Toxins A and B kit was conducted in northern New Jersey, USA. Stool collection times and receiving times were recorded for each specimen. The unrefrigerated handling time was calculated for each.
RESULTS: A total of 1126 fecal specimens were submitted. We excluded 72 fecal specimens due to incomplete documentation. We included 1054 fecal specimens collected from 636 hospitalized patients. A total of 132 out of 1054 specimens (12.5%) tested positive for C. difficile toxins. Nine hundred and fifty-four specimens were unrefrigerated for 13 h or less, of which 127 (13.3%) tested positive. Five (5%) of the 100 specimens that were unrefrigerated for more than 13 h tested positive (p = 0.02).
CONCLUSION: C. difficile toxins can still be detected up to 13 h after collection in unrefrigerated human fecal specimens. However, fecal specimens should be processed according to the current recommendations to ensure the reliability of EIA testing until the results of our study are confirmed with prospective studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20740339     DOI: 10.1007/s12664-010-0040-1

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  22 in total

Review 1.  Clostridium difficile infection: risk factors, medical and surgical management.

Authors:  P J Klingler; P P Metzger; M H Seelig; P D Pettit; J M Knudsen; S A Alvarez
Journal:  Dig Dis       Date:  2000       Impact factor: 2.404

2.  C. difficile: by the numbers.

Authors:  Laura Eggertson
Journal:  CMAJ       Date:  2004-11-02       Impact factor: 8.262

3.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

4.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

Review 5.  Diagnostic procedures for isolation and characterization of Clostridium difficile associated with enterocolitis in foals.

Authors:  R L Jones
Journal:  J Vet Diagn Invest       Date:  1989-01       Impact factor: 1.279

6.  Survival of Clostridium difficile and its toxins in equine feces: implications for diagnostic test selection and interpretation.

Authors:  J S Weese; H R Staempfli; J F Prescott
Journal:  J Vet Diagn Invest       Date:  2000-07       Impact factor: 1.279

7.  Evaluation of three commercial enzyme immunoassay kits for detecting faecal Clostridium difficile toxins.

Authors:  S A Arrow; L Croese; R A Bowman; T V Riley
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

8.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

9.  Comparison of methods for recovery of Clostridium difficile from an environmental surface.

Authors:  B P Buggy; K H Wilson; R Fekety
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

Review 10.  Renewed interest in a difficult disease: Clostridium difficile infections--epidemiology and current treatment strategies.

Authors:  Lynne V McFarland
Journal:  Curr Opin Gastroenterol       Date:  2009-01       Impact factor: 3.287

View more
  5 in total

1.  Diagnostic approach to Clostridium difficile infection.

Authors:  Chetana Vaishnavi
Journal:  Indian J Gastroenterol       Date:  2010-08-18

2.  Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.

Authors:  Johanna Sandlund; Amelita Bartolome; Anna Almazan; Stanley Tam; Sheryl Biscocho; Salina Abusali; Jeffrey J Bishop; Niamh Nolan; Joel Estis; John Todd; Stephen Young; Fiona Senchyna; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

3.  Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests.

Authors:  Johanna Sandlund; Joel Estis; Phoebe Katzenbach; Niamh Nolan; Kirstie Hinson; Jennifer Herres; Troy Pero; Gwyn Peterson; Jeung-Mi Schumaker; Craig Stevig; Rhonda Warren; Tsubasa West; Siu-Kei Chow
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

4.  Ultrasensitive Detection of Clostridioides difficile Toxins in Stool by Use of Single-Molecule Counting Technology: Comparison with Detection of Free Toxin by Cell Culture Cytotoxicity Neutralization Assay.

Authors:  Glen Hansen; Stephen Young; Alan H B Wu; Emily Herding; Vickie Nordberg; Ray Mills; Christen Griego-Fullbright; Aaron Wagner; Chui Mei Ong; Shawna Lewis; Joseph Yoon; Joel Estis; Johanna Sandlund; Emily Friedland; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

5.  Clostridium difficile in Crete, Greece: epidemiology, microbiology and clinical disease.

Authors:  G Samonis; K Z Vardakas; G S Tansarli; D Dimopoulou; G Papadimitriou; D P Kofteridis; S Maraki; M Karanika; M E Falagas
Journal:  Epidemiol Infect       Date:  2015-05-20       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.